We are live on !
Find out more
Mitchell Sinkler & Starr Portfolio holdings
AUM
$247M
Turnover
6.25%
1-Year Est. Return
20.34%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+20.34%
3 Year Est. Return
+85.59%
5 Year Est. Return
+95.74%
10 Year Est. Return
+283.23%
AUM
$456M
AUM Growth
–
Cap. Flow
+$464M
Cap. Flow % of AUM
Cap. Flow %
101.68%
Top 10 Holdings %
Top 10 Hldgs %
37.08%
Holding
153
New
153
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$26.7M |
| 2 |
ExxonMobil
XOM
|
+$26.2M |
| 3 |
Merck
MRK
|
+$23.3M |
| 4 |
Procter & Gamble
PG
|
+$22.4M |
| 5 |
GE Aerospace
GE
|
+$14.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Staples | 17.18% |
| 3 | Energy | 15.94% |
| 4 | Industrials | 12.86% |
| 5 | Miscellaneous | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$688B
| $27M | 5.93% |
+315,040
| New | +$26.7M |
2013 Q2
0 quarters
|
|
|
2
ExxonMobil
XOM
$696B
| $26.3M | 5.76% |
+290,962
| New | +$26.2M |
2013 Q2
0 quarters
|
|
|
3
Merck
MRK
$364B
| $23.2M | 5.08% |
+522,494
| New | +$23.3M |
2013 Q2
0 quarters
|
|
|
4
Procter & Gamble
PG
$394B
| $22M | 4.82% |
+285,460
| New | +$22.4M |
2013 Q2
0 quarters
|
|
|
5
GE Aerospace
GE
$344B
| $14.2M | 3.12% |
+128,201
| New | +$14.2M |
2013 Q2
0 quarters
|
|
6
Chevron
CVX
$429B
| $12.8M | 2.81% |
+108,408
| New | +$13.1M |
2013 Q2
0 quarters
|
|
7
3M
MMM
$94.7B
| $12.8M | 2.8% |
+139,845
| New | +$12.7M |
2013 Q2
0 quarters
|
|
8
PepsiCo
PEP
$198B
| $10.6M | 2.32% |
+129,559
| New | +$10.6M |
2013 Q2
0 quarters
|
|
9
Emerson Electric
EMR
$91.3B
| $10.5M | 2.31% |
+192,773
| New | +$10.8M |
2013 Q2
0 quarters
|
|
10
AbbVie
ABBV
$521B
| $9.7M | 2.12% |
+233,581
| New | +$10.2M |
2013 Q2
0 quarters
|
|
11
Kimberly-Clark
KMB
$67.2B
| $9.36M | 2.05% |
+100,542
| New | +$9.7M |
2013 Q2
0 quarters
|
|
12
Colgate-Palmolive
CL
$79.2B
| $9.08M | 1.99% |
+158,506
| New | +$9.41M |
2013 Q2
0 quarters
|
|
13
AT&T
T
$149B
| $8.84M | 1.94% |
+330,505
| New | +$9.18M |
2013 Q2
0 quarters
|
|
14
Automatic Data Processing
ADP
$122B
| $8.8M | 1.93% |
+145,614
| New | +$8.69M |
2013 Q2
0 quarters
|
|
15
Abbott
ABT
$188B
| $8.1M | 1.78% |
+232,347
| New | +$8.52M |
2013 Q2
0 quarters
|
|
16
RPM International
RPM
$13.2B
| $7.86M | 1.72% |
+246,085
| New | +$7.9M |
2013 Q2
0 quarters
|
|
17
Tortoise Energy Infrastructure Corp
TYG
$969M
| $7.43M | 1.63% |
+39,961
| New | +$7.29M |
2013 Q2
0 quarters
|
|
18
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $6.96M | 1.53% |
+157,478
| New | +$7.37M |
2013 Q2
0 quarters
|
|
19
Southern Company
SO
$109B
| $6.26M | 1.37% |
+141,909
| New | +$6.53M |
2013 Q2
0 quarters
|
|
20
J.M. Smucker
SJM
$14.2B
| $6.21M | 1.36% |
+60,164
| New | +$6.13M |
2013 Q2
0 quarters
|
|
21
Duke Energy
DUK
$101B
| $6.18M | 1.36% |
+91,546
| New | +$6.47M |
2013 Q2
0 quarters
|
|
22
Pfizer
PFE
$165B
| $6.1M | 1.34% |
+229,686
| New | +$6.35M |
2013 Q2
0 quarters
|
|
23
Verizon
VZ
$192B
| $6.09M | 1.34% |
+120,970
| New | +$6.17M |
2013 Q2
0 quarters
|
|
24
Coca-Cola
KO
$427B
| $5.8M | 1.27% |
+144,616
| New | +$5.99M |
2013 Q2
0 quarters
|
|
25
ConocoPhillips
COP
$168B
| $5.6M | 1.23% |
+92,551
| New | +$5.63M |
2013 Q2
0 quarters
|
|
Similar funds
TSM
TBBL
VM
Mitchell Sinkler & Starr's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Mitchell Sinkler & Starr, which disclosed 153 positions worth $456M. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Johnson & Johnson: 315,040 shares worth $27M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Energy.
- Mitchell Sinkler & Starr's largest Q2 2013 buy was Johnson & Johnson: 315,040 shares worth $27M.
- Mitchell Sinkler & Starr's ten largest holdings make up 37% of its $456M portfolio in Q2 2013.
- Mitchell Sinkler & Starr disclosed 153 positions in Q2 2013, its first 13F filing on record.
Based on Mitchell Sinkler & Starr's 13F filing for Q2 2013, filed 24 Jul 2013.